| INK Ultra Money Free |
Latest 10 SEC filings (by transaction date) for RXRX within the last 6 months | [?] |
![]() ![]() |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
May 18/22 | May 16/22 | Virani Shafique | Direct Ownership | Class A Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 ![]() | -870 | $5.67 |
May 18/22 | May 16/22 | Doyle Ramona | Direct Ownership | Class A Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 ![]() | -832 | $5.67 |
May 18/22 | May 16/22 | Secora Michael | Direct Ownership | Class A Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 ![]() | -1,069 | $5.67 |
May 18/22 | May 16/22 | Larson Tina Marriott | Direct Ownership | Class A Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 ![]() | -1,458 | $5.67 |
May 18/22 | May 16/22 | Gibson Christopher | Direct Ownership | Class A Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 ![]() | -5,764 | $5.67 |
May 6/22 | May 5/22 | Gibson Christopher | Indirect Ownership | Class B Common Stock | C - Conversion ![]() | -1,000 | |
May 6/22 | May 5/22 | Gibson Christopher | Indirect Ownership | Class B Common Stock | C - Conversion ![]() | -1,000 | |
May 6/22 | May 5/22 | Gibson Christopher | Indirect Ownership | Class B Common Stock | C - Conversion ![]() | -500 | |
May 6/22 | May 5/22 | Gibson Christopher | Direct Ownership | Class B Common Stock | C - Conversion ![]() | -18,500 | |
May 6/22 | May 5/22 | Gibson Christopher | Indirect Ownership | Class A Common Stock | S - Open market or private sale ![]() | -1,000 | $6.44 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for RXRX within the last 6 months | [?] |
![]() ![]() |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
May 18/22 | May 16/22 | Virani Shafique | Direct Ownership | Class A Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 ![]() | -870 | $5.67 |
May 18/22 | May 16/22 | Doyle Ramona | Direct Ownership | Class A Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 ![]() | -832 | $5.67 |
May 18/22 | May 16/22 | Secora Michael | Direct Ownership | Class A Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 ![]() | -1,069 | $5.67 |
May 18/22 | May 16/22 | Larson Tina Marriott | Direct Ownership | Class A Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 ![]() | -1,458 | $5.67 |
May 18/22 | May 16/22 | Gibson Christopher | Direct Ownership | Class A Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 ![]() | -5,764 | $5.67 |
May 6/22 | May 4/22 | Gibson Christopher | Indirect Ownership | Class A Common Stock | C - Conversion ![]() | 1,000 | |
May 6/22 | May 4/22 | Gibson Christopher | Indirect Ownership | Class A Common Stock | S - Open market or private sale ![]() | -1,000 | $6.48 |
May 6/22 | May 4/22 | Gibson Christopher | Indirect Ownership | Class A Common Stock | C - Conversion ![]() | 1,000 | |
May 6/22 | May 4/22 | Gibson Christopher | Indirect Ownership | Class A Common Stock | S - Open market or private sale ![]() | -500 | $6.47 |
May 6/22 | May 4/22 | Gibson Christopher | Indirect Ownership | Class A Common Stock | C - Conversion ![]() | 500 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Regeneron Pharmaceuticals (OQ:REGN) |
Intra-Cellular Therapies (OQ:ITCI) |
Epizyme (OQ:EPZM) |